| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZNF91_0001200 | Exon-Intergenic | chr19:23521529-23525067 | chr19:23338727-23342265 | 161 nt | 0.4534 |
| hsa_ZNF91_0000800 | Intergenic-Exon | chr19:23521529-23545161 | chr19:23338727-23362359 | 250 nt | 0.3040 |
| hsa_ZNF91_0001300 | Intergenic-Exon | chr19:23521529-23556639 | chr19:23338727-23373837 | 96 nt | 0.4583 |
| hsa_ZNF91_0000900 | Intergenic-Exon | chr19:23521529-23557535 | chr19:23338727-23374733 | 520 nt | 0.4865 |
| hsa_ZNF91_0001400 | Intergenic-Exon | chr19:23521529-23557566 | chr19:23338727-23374764 | 127 nt | 0.4646 |
| hsa_ZNF91_0001000 | Exon-Intergenic | chr19:23521529-23559132 | chr19:23338727-23376330 | 250 nt | 0.3240 |
| hsa_chr19_0140600 | Intergenic-Intergenic | chr19:23521625-23521789 | chr19:23338823-23338987 | 165 nt | 0.4970 |
| hsa_chr19_0140700 | Intergenic-Intergenic | chr19:23521630-23521789 | chr19:23338828-23338987 | 160 nt | 0.4938 |
| hsa_ZNF91_0001600 | Intron-Intron | chr19:23522033-23525067 | chr19:23339231-23342265 | 126 nt | 0.3810 |
| hsa_ZNF91_0001700 | Intron-Intron | chr19:23522033-23542009 | chr19:23339231-23359207 | 30 nt | 0.1667 |
A study in pancreatic cancer cells demonstrated that the circZNF91 facilitates glycolysis and gemcitabine chemoresistance via the SIRT1/HIF-1α axis [Huang et al. DOI:10.3390/cells11091381].